Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With Sepsis

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

June 30, 2011

Conditions
Acute Respiratory Distress SyndromeAcute Lung InjurySepsis
Interventions
DEVICE

CytoSorb Hemoperfusion

Daily hemoperfusion for 6 hours with CytoSorb device

Trial Locations (6)

Unknown

Aachen

Berlin

Bonn

Erfurt

Göttingen

Kiel

Sponsors
All Listed Sponsors
lead

MedaSorb Technologies, Inc

INDUSTRY